Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PAX5::AUTS2 childhood B-ALL: a relapse-prone genetic subtype with frequent central nervous system involvement and a poor outcome.
Caye-Eude A, Fazio G, Pastorczak A, Boer JM, Steinemann D, Ganguli D, Sonneveld E, Haslinger S, D'Andrea L, Bradtke J, Lopes BA, Zaliova M, Escherich G, König M, Fortschegger K, Inthal A, Stasevich I, Emerenciano M, Trka J, Castillo L, Parihar M, Moorman AV, Bergmann AK, den Boer ML, Młynarski W, Cazzaniga G, Cavé H, Nebral K, Schinnerl D, Strehl S. Caye-Eude A, et al. Among authors: escherich g. Leukemia. 2024 Dec 19. doi: 10.1038/s41375-024-02502-5. Online ahead of print. Leukemia. 2024. PMID: 39702796 No abstract available.
Case report: Granulocyte-macrophage colony-stimulating factor sargramostim did not rescue the neutrophil phenotype in two patients with JAGN1-mutant severe congenital neutropenia.
Farmand S, Aydin SE, Wustrau K, Böhm S, Ayuk F, Escherich G, Skokowa J, Müller I, Lehmberg K. Farmand S, et al. Among authors: escherich g. Front Immunol. 2024 Sep 2;15:1373495. doi: 10.3389/fimmu.2024.1373495. eCollection 2024. Front Immunol. 2024. PMID: 39286252 Free PMC article.
Effectiveness of structured, multidisciplinary long-term care for pediatric cancer survivors: protocol of the multicenter, randomized-controlled AELKI study.
Schmidt H, Baust K, Calaminus G, Hohls L, Tetzner K, Griech N, Haugke H, Baltus H, Elsner S, Katalinic A, Becker H, Cytera C, Gebauer J, Kock-Schoppenhauer AK, Neumann A, Denzer C, Schündeln MM, Faber J, Sattler C, Frühwald MC, Borgmann-Staudt A, Barnbrock A, Metzler M, Escherich G, König IR, Menrath I, Langer T. Schmidt H, et al. Among authors: escherich g. Trials. 2024 Sep 8;25(1):597. doi: 10.1186/s13063-024-08377-2. Trials. 2024. PMID: 39245714 Free PMC article.
Pediatric T-cell lymphoblastic lymphomas but not leukemias harbor TRB::NOTCH1 fusions with unfavorable outcome.
Te Vrugt M, Wessolowski J, Randau G, Alfert A, Mueller S, Scholten K, Sopalla C, Lanvers-Kaminsky C, Hotfilder M, Lamp F, Damm-Welk C, Luedersen J, Escherich G, Zur Stadt U, Behrmann L, Woessmann W, Oschlies I, Marzi M, Zimmermann M, Burkhardt B. Te Vrugt M, et al. Among authors: escherich g. Blood. 2024 Sep 26;144(13):1412-1417. doi: 10.1182/blood.2024025307. Blood. 2024. PMID: 39024510
No clear benefit of preventive cranial radiotherapy in childhood Philadelphia-positive acute lymphoblastic leukemia: a retrospective analysis of the EsPhALL2010 study.
Conter V, Valsecchi MG, De Lorenzo P, Gandemer V, Heyman M, Saha V, Diaz P, Li CK, Attarbaschi A, Escherich G, Stary J, Schrappe M, Pieters R, Cario G, Biondi A. Conter V, et al. Among authors: escherich g. Haematologica. 2024 Nov 1;109(11):3766-3770. doi: 10.3324/haematol.2024.285253. Haematologica. 2024. PMID: 39021218 Free PMC article. No abstract available.
Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction.
Moorman AV, Enshaei A, Murdy D, Joy M, Boer JM, den Boer ML, Pieters R, de Haas V, Horstmann MA, Escherich G, Johansson B, Marquart HV, Schmiegelow K, Hancock J, Moppett J, Heyman M. Moorman AV, et al. Among authors: escherich g. Leukemia. 2024 Sep;38(9):2023-2026. doi: 10.1038/s41375-024-02329-0. Epub 2024 Jul 5. Leukemia. 2024. PMID: 38965371 Free PMC article. No abstract available.
The German sickle cell disease registry reveals a surprising risk of acute splenic sequestration and an increased transfusion requirement in patients with compound heterozygous sickle cell disease HbS/β-thalassaemia and no or low HbA expression.
Allard P, Tagliaferri L, Weru V, Cario H, Lobitz S, Grosse R, Bleeke M, Oevermann L, Hakimeh D, Jarisch A, Kopp-Schneider A, Kulozik AE, Kunz JB; German Sickle Cell Disease Study Group; Lassay L. Allard P, et al. Eur J Haematol. 2024 Oct;113(4):501-509. doi: 10.1111/ejh.14259. Epub 2024 Jun 30. Eur J Haematol. 2024. PMID: 38946051
Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial.
Corbacioglu S, Lode H, Ellinger S, Zeman F, Suttorp M, Escherich G, Bochennek K, Gruhn B, Lang P, Rohde M, Debatin KM, Steinbach D, Beilken A, Ladenstein R, Spachtholz R, Heiss P, Hellwig D, Tröger A, Koller M, Menhart K, Riemenschneider MJ, Zoubaa S, Kietz S, Jakob M, Sommer G, Heise T, Hundsdörfer P, Kühnle I, Dilloo D, Schönberger S, Schwabe G, von Luettichau I, Graf N, Schlegel PG, Frühwald M, Jorch N, Paulussen M, Schneider DT, Metzler M, Leipold A, Nathrath M, Imschweiler T, Christiansen H, Schmid I, Crazzolara R, Niktoreh N, Cario G, Faber J, Demmert M, Babor F, Fröhlich B, Bielack S, Bernig T, Greil J, Eggert A, Simon T, Foell J. Corbacioglu S, et al. Among authors: escherich g. Lancet Oncol. 2024 Jul;25(7):922-932. doi: 10.1016/S1470-2045(24)00202-X. Lancet Oncol. 2024. PMID: 38936379 Free article. Clinical Trial.
Severe steroid-related neuropsychiatric symptoms during paediatric acute lymphoblastic leukaemia therapy-An observational Ponte di Legno Toxicity Working Group Study.
Anastasopoulou S, Swann G, Andres-Jensen L, Attarbaschi A, Barzilai-Birenboim S, Erdelyi DJ, Escherich G, Hamadeh L, Harila A, Lopez-Lopez E, McGowan S, Möricke A, Putti C, Sagi JC, Schmiegelow K, Ullrich NJ, van der Sluis IM, Wahid QU, Winick N, Sramkova L, Zalcberg Y, Zapotocka E, Bhojwani D, Halsey C; Ponte Di Legno Neurotoxicity Working Group. Anastasopoulou S, et al. Among authors: escherich g. Br J Haematol. 2024 Oct;205(4):1450-1459. doi: 10.1111/bjh.19610. Epub 2024 Jun 25. Br J Haematol. 2024. PMID: 38924051
176 results